Hepatic echinococcosis: Clinical and therapeutic aspects

World Journal of Gastroenterology

Volumn 18, Issue 13, 2012, Pages 1448-1458

  Nunnari, Giuseppe ^a,b   Pinzone, Marilia R ^a   Gruttadauria, Salvatore ^a   Celesia, Benedetto M ^a   Madeddu, Giordano ^c   Malaguarnera, Giulia ^a   Pavone, Piero ^d   Cappellani, Alessandro ^a   Cacopardo, Bruno ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Albendazole; Alveolar echinococcosis; Cystic echinococcosis; Diagnosis; Hydatidosis; Liver; PAIR; Treatment

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B LIPID COMPLEX; IMIDAZOLE DERIVATIVE; MEBENDAZOLE; NITAZOXANIDE; PRAZIQUANTEL;

ABDOMINAL PAIN; ALOPECIA; ANAPHYLAXIS; ASIA; ASPIRATION; AUSTRIA; ECHINOCOCCUS GRANULOSUS; ECHINOCOCCUS MULTILOCULARIS; ECHOGRAPHY; ENDEMIC DISEASE; FATIGUE; FRANCE; GERMANY; HEPATOMEGALY; HUMAN; IMMUNE RESPONSE; JAUNDICE; LIFE EXPECTANCY; LIVER FAILURE; LIVER HYDATID CYST; LIVER TOXICITY; MINIMALLY INVASIVE SURGERY; NAUSEA; NEUTROPENIA; NONHUMAN; NORTH AMERICA; PUNCTURE; QUALITY OF LIFE; REVIEW; SERODIAGNOSIS; SURGICAL TECHNIQUE; SYMPTOM; TISSUE INJURY;

EID: 84859334829     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i13.1448     Document Type: Review

References (121)

1. Rausch R, D'Alesandro A. The epidemiology of echinococcosis caused by Echinococcus oligarthrus and E vogeli in the neotropics. In: Craig P, Pawlowksi Z. Cestode zoonoses: echinococcosis and cysticercosis. Amsterdam: IOS Press, 2002: 107-130
2. D'Alesandro A. Polycystic echinococcosis in tropical America: Echinococcus vogeli and E oligarthrus. Acta Trop 1997; 67: 43-65
3. Polat P, Kantarci M, Alper F, Suma S, Koruyucu MB, Okur A. Hydatid disease from head to toe. Radiographics 2003; 23: 475-494; quiz 536-537
4. McManus DP, Thompson RC. Molecular epidemiology of cystic echinococcosis. Parasitology 2003; 127 Suppl: S37-S51
5. Thompson RC, McManus DP. Towards a taxonomic revision of the genus Echinococcus. Trends Parasitol 2002; 18: 452-457
6. Thompson RC, McManus DP. Aetiology: parasites and lifecycles. In: Eckert J, Gemmell M, Meslin FX, Pawlowski Z. WHOI/OIE Manual on echinococcosis in humans and animals: a public health problem of global concern. Paris: World Organisation for Animal Health, 2001: 1-19
7. Thompson RC. Biology and systematics of Echinococcus. In: Thompson RCA, Lymbery AJ. The biology of Echinococcus and hydatid disease. Wallingford: CAB International, 1995: 1-50
8. Zhang W, Li J, McManus DP. Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev 2003; 16: 18-36
9. Archer GT, Robson JE, Thompson AR. Eosinophilia and mast cell hyperplasia induced by parasite phospholipid. Pathology 1977; 9: 137-153
10. Riganò R, Profumo E, Siracusano A. New perspectives in the immunology of Echinococcus granulosus infection. Parassitologia 1997; 39: 275-277
11. Riganò R, Profumo E, Teggi A, Siracusano A. Production of IL-5 and IL-6 by peripheral blood mononuclear cells (PBMC) from patients with Echinococcus granulosus infection. Clin Exp Immunol 1996; 105: 456-459
12. Vuitton DA. Echinococcosis and allergy. Clin Rev Allergy Immunol 2004; 26: 93-104
13. Touil-Boukoffa C, Bauvois B, Sancéau J, Hamrioui B, Wietzerbin J. Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-gamma levels. Biochimie 1998; 80: 739-744
14. McManus DP, Bryant C. Biochemistry, physiology and molecular biology of Echinococcus. In: RCA Thompson and AJ Lymbery, editors. The biology of Echinococcus and hydatid disease. Wallingford: CAB International, 1995: 355-410
15. Riganò R, Profumo E, Ioppolo S, Notargiacomo S, Ortona E, Teggi A, Siracusano A. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol 1995; 102: 281-285
16. Vuitton DA. The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 2003; 85: 119-132
17. Ferreira AM, Würzner R, Hobart MJ, Lachmann PJ. Study of the in vitro activation of the complement alternative pathway by Echinococcus granulosus hydatid cyst fluid. Parasite Immunol 1995; 17: 245-251
18. Annen JM, Köhler P, Eckert J. Cytotoxicity of Echinococcus granulosus cyst fluid in vitro. Z Parasitenkd 1981; 65: 79-88
19. Dixon JB, Jenkins P. Immunology of mammalian metacestode infections. I. Antigens, protective immunity and immunopathology. Helm Abstr 1995; 64: 532-542
20. Wang Q, Qiu JM, Schantz P, He JG, Ito A, Liu FJ. Investigation of risk factors for development of human hydatidosis among households raising livestock in Tibetan areas of western Sichuan province. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2001; 19: 93-96
21. Eckert J, Schantz P, Gasser R. Geographic distribution and prevalence. In: Eckert J, Gemmell MA, Meslin FX, Pawlowski ZS, editors. WHOI/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. Paris: World Organisation for Animal Health, 2001: 100-141
22. Ito A, Urbani C, Jiamin Q, Vuitton DA, Dongchuan Q, Heath DD, Craig PS, Zheng F, Schantz PM. Control of echinococcosis and cysticercosis: a public health challenge to international cooperation in China. Acta Trop 2003; 86: 3-17
23. Todorov T, Boeva V. Human echinococcosis in Bulgaria: a comparative epidemiological analysis. Bull World Health Organ 1999; 77: 110-118
24. Shaikenov BS, Torgerson PR. Distribution of Echinococcus multilocularis in Kazakhstan. In: Craig P, Pawlowski Z. Cestode zoononoses: echinococcosis and cysticercosis, an emergent and global problem. Amsterdam: IOS Press, 2002: 299-307
25. Shaikenov BS, Vaganov TF, Torgerson PR. Cystic echinococcosis in Kazakhstan: an emerging disease since independence from the Soviet Union. Parasitol Today 1999; 15: 172-174
26. Moro PL, Cavero CA, Tambini M, Briceño Y, Jiménez R, Cabrera L. Identification of risk factors for cystic echinococcosis in a peri-urban population of Peru. Trans R Soc Trop Med Hyg 2008; 102: 75-78
27. Campos-Bueno A, López-Abente G, Andrés-Cercadillo AM. Risk factors for Echinococcus granulosus infection: a casecontrol study. Am J Trop Med Hyg 2000; 62: 329-334
28. Macpherson CNL. Epidemiology of Echinococcus granulosus in transhumant situations. In: Eckert J, Gemmell MA, Meslin FX, Pawlowski ZS, editors. WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern. Paris: World Organisation for Animal Health, 2001: 156-163
29. Prousalidis J, Tzardinoglou E, Kosmidis C, Katsohis K, Aletras O. Surgical management of calcified hydatid cysts of the liver. HPB Surg 1999; 11: 253-259
30. Atli M, Kama NA, Yuksek YN, Doganay M, Gozalan U, Kologlu M, Daglar G. Intrabiliary rupture of a hepatic hydatid cyst: associated clinical factors and proper management. Arch Surg 2001; 136: 1249-1255
31. Kammerer WS, Schantz PM. Echinococcal disease. Infect Dis Clin North Am 1993; 7: 605-618
32. Pawlowski Z, Eckert J, Vuitton DA, Ammann RW, Kern P, Craig PS. Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert J, Gemmell MA, Meslin FX, Pawlowski Z, editors. WHO/OIE Manual on Echinococcosis in humans and animals. Paris: Office International des Epizooties, 2001: 20-71
33. Ergüney S, Tortum O, Taspinar AH, Ertem M, Gazioǧlu E. [Complicated hydatid cysts of the liver]. Ann Chir 1991; 45: 584-589
34. Pedrosa I, Saíz A, Arrazola J, Ferreirós J, Pedrosa CS. Hydatid disease: radiologic and pathologic features and complications. Radiographics 2000; 20: 795-817
35. Cohen H, Paolillo E, Bonifacino R, Botta B, Parada L, Cabrera P, Snowden K, Gasser R, Tessier R, Dibarboure L, Wen H, Allan JC, Soto de Alfaro H, Rogan MT, Craig PS. Human cystic echinococcosis in a Uruguayan community: a sonographic, serologic, and epidemiologic study. Am J Trop Med Hyg 1998; 59: 620-627
36. Shambesh MA, Craig PS, Macpherson CN, Rogan MT, Gusbi AM, Echtuish EF. An extensive ultrasound and serologic study to investigate the prevalence of human cystic echinococcosis in northern Libya. Am J Trop Med Hyg 1999; 60: 462-468
37. WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop 2003; 85: 253-261
38. Gharbi HA, Hassine W, Brauner MW, Dupuch K. Ultrasound examination of the hydatic liver. Radiology 1981; 139: 459-463
39. Hosch W, Junghanss T, Stojkovic M, Brunetti E, Heye T, Kauffmann GW, Hull WE. Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst con-tents. NMR Biomed 2008; 21: 734-754
40. Zhang W, McManus DP. Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol 2006; 47: 24-41
41. Ito A. Serologic and molecular diagnosis of zoonotic larval cestode infections. Parasitol Int 2002; 51: 221-235
42. Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev 1992; 5: 248-261
43. Craig PS, Rogan MT, Campos-Ponce M. Echinococcosis: disease, detection and transmission. Parasitology 2003; 127 Suppl: S5-20
44. Liu D, Rickard MD, Lightowlers MW. Assessment of monoclonal antibodies to Echinococcus granulosus antigen 5 and antigen B for detection of human hydatid circulating antigens. Parasitology 1993; 106 (Pt 1): 75-81
45. Ortona E, Riganò R, Margutti P, Notargiacomo S, Ioppolo S, Vaccari S, Barca S, Buttari B, Profumo E, Teggi A, Siracusano A. Native and recombinant antigens in the immunodiagnosis of human cystic echinococcosis. Parasite Immunol 2000; 22: 553-559
46. Poretti D, Felleisen E, Grimm F, Pfister M, Teuscher F, Zuercher C, Reichen J, Gottstein B. Differential immunodiagnosis between cystic hydatid disease and other cross-reactive pathologies. Am J Trop Med Hyg 1999; 60: 193-198
47. Hira PR, Shweiki H, Lindberg LG, Shaheen Y, Francis I, Leven H, Behbehani K. Diagnosis of cystic hydatid disease: role of aspiration cytology. Lancet 1988; 2: 655-657
48. Khabiri AR, Bagheri F, Assmar M, Siavashi MR. Analysis of specific IgE and IgG subclass antibodies for diagnosis of Echinococcus granulosus. Parasite Immunol 2006; 28: 357-362
49. Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114: 1-16
50. Erdener A, Ozok G, Demircan M. Surgical treatment of hepatic hydatid disease in children. Eur J Pediatr Surg 1992; 2: 87-89
51. Perdomo R, Alvarez C, Monti J, Ferreira C, Chiesa A, Carbó A, Alvez R, Grauert R, Stern D, Carmona C, Yarzabal L. Principles of the surgical approach in human liver cystic echinococcosis. Acta Trop 1997; 64: 109-122
52. Cirenei A, Bertoldi I. Evolution of surgery for liver hydatidosis from 1950 to today: analysis of a personal experience. World J Surg 2001; 25: 87-92
53. Dziri C, Haouet K, Fingerhut A. Treatment of hydatid cyst of the liver: where is the evidence? World J Surg 2004; 28: 731-736
54. Ammann RW, Eckert J. Cestodes. Echinococcus. Gastroenterol Clin North Am 1996; 25: 655-689
55. Arif SH, Shams-Ul-Bari NA, Zargar SA, Wani MA, Tabassum R, Hussain Z, Baba AA, Lone RA. Albendazole as an adjuvant to the standard surgical management of hydatid cyst liver. Int J Surg 2008; 6: 448-451
56. Informal Working Group on Echinococcosis. PAIR: Puncture, Aspiration, Injection, Re-Aspiration. An Option for the Treatment of Cystic Echinococcosis. Geneva: WHO, 2003
57. Khuroo MS, Dar MY, Yattoo GN, Zargar SA, Javaid G, Khan BA, Boda MI. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology 1993; 104: 1452-1459
58. Smego RA, Bhatti S, Khaliq AA, Beg MA. Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a metaanalysis. Clin Infect Dis 2003; 37: 1073-1083
59. Vutova K, Mechkov G, Vachkov P, Petkov R, Georgiev P, Handjiev S, Ivanov A, Todorov T. Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration. Ann Trop Med Parasitol 1999; 93: 357-365
60. Senyüz OF, Yeşildag E, Celayir S. Albendazole therapy in the treatment of hydatid liver disease. Surg Today 2001; 31: 487-491
61. Nahmias J, Goldsmith R, Soibelman M, el-On J. Three-to 7-year follow-up after albendazole treatment of 68 patients with cystic echinococcosis (hydatid disease). Ann Trop Med Parasitol 1994; 88: 295-304
62. Kumar A, Lal BK, Chattopadhyay TK. Hydatid disease of the liver--non surgical options. J Assoc Physicians India 1993; 41: 437-438
63. Stojkovic M, Zwahlen M, Teggi A, Vutova K, Cretu CM, Virdone R, Nicolaidou P, Cobanoglu N, Junghanss T. Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLoS Negl Trop Dis 2009; 3: e524
64. Cobo F, Yarnoz C, Sesma B, Fraile P, Aizcorbe M, Trujillo R, Diaz-de-Liaño A, Ciga MA. Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosus. Trop Med Int Health 1998; 3: 462-466
65. Eckert J, Gemmell MA, Meslin FX, Pawłowski ZS. WHO/ OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern. World Organisation for Animal Health (Office International des Epizooties) and World Health Organization. Paris: WHO, 2001
66. Eckert J. Alveolar echinococcosis (Echinococcus multilocularis) and other forms of echinococcosis (Echinococcus oligarthrus and Echinococcus vogeli). In: Palmer SR, Soulsby EJL, Simpson DIH, editors. Oxford: Oxford University Press, 1998: 689-716
67. Ricard-Blum S, Bresson-Hadni S, Guerret S, Grenard P, Volle PJ, Risteli L, Grimaud JA, Vuitton DA. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology 1996; 111: 172-182
68. Grenard P, Bresson-Hadni S, El Alaoui S, Chevallier M, Vuitton DA, Ricard-Blum S. Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol 2001; 35: 367-375
69. Vuitton DA, Guerret-Stocker S, Carbillet JP, Mantion G, Miguet JP, Grimaud JA. Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd 1986; 72: 97-104
70. Gottstein B, Hemphill A. Immunopathology of echinococcosis. Chem Immunol 1997; 66: 177-208
71. Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol 1998; 20: 81-91
72. Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA. Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite 1998; 5: 231-237
73. Sturm D, Menzel J, Gottstein B, Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 1995; 63: 1688-1697
74. Godot V, Harraga S, Deschaseaux M, Bresson-Hadni S, Gottstein B, Emilie D, Vuitton DA. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis. Eur Cytokine Netw 1997; 8: 401-408
75. Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron E, Gottstein B, Vuitton DA. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clin Exp Immunol 2000; 121: 484-490
76. Godot V, Harraga S, Beurton I, Tiberghien P, Sarciron E, Gottstein B, Vuitton DA. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype. Clin Exp Immunol 2000; 121: 491-498
77. Bresson-Hadni S, Liance M, Meyer JP, Houin R, Bresson JL, Vuitton DA. Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol 1990; 82: 378-383
78. Rakha NK, Dixon JB, Carter SD, Craig PS, Jenkins P, Folkard S. Echinococcus multilocularis antigens modify accessory cell function of macrophages. Immunology 1991; 74: 652-656
79. Kizaki T, Ishige M, Bingyan W, Day NK, Good RA, Onoé K. Generation of CD8+ suppressor T cells by protoscoleces of Echinococcus multilocularis in vitro. Immunology 1993; 79: 412-417
80. Vuitton DA, Bresson-Hadni S, Laroche L, Kaiserlian D, Guerret-Stocker S, Bresson JL, Gillet M. Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol 1989; 78: 67-74
81. Frosch PM, Frosch M, Pfister T, Schaad V, Bitter-Suermann D. Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol 1991; 48: 121-130
82. Gottstein B. Echinococcus multilocularis: antigenic variance between different parasite isolates. Parasitol Res 1991; 77: 359-361
83. Bretagne S, Assouline B, Vidaud D, Houin R, Vidaud M. Echinococcus multilocularis: microsatellite polymorphism in U1 snRNA genes. Exp Parasitol 1996; 82: 324-328
84. Romig T, Dinkel A, Mackenstedt U. The present situation of echinococcosis in Europe. Parasitol Int 2006; 55 Suppl: S187-S191
85. Shaikenov BS. Distribution and ecology of Echinococcus multilocularis in Central Asia. Parasitol Int 2006; 55 Suppl: S213-S219
86. Craig PS, Deshan L, MacPherson CN, Dazhong S, Reynolds D, Barnish G, Gottstein B, Zhirong W. A large focus of alveolar echinococcosis in central China. Lancet 1992; 340: 826-831
87. Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis 2003; 9: 343-349
88. Eckert J, Deplazes P. Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures. Parasitol Today 1999; 15: 315-319
89. Schweiger A, Ammann RW, Candinas D, Clavien PA, Eckert J, Gottstein B, Halkic N, Muellhaupt B, Prinz BM, Reichen J, Tarr PE, Torgerson PR, Deplazes P. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis 2007; 13: 878-882
90. Eckert J, Conraths FJ, Tackmann K. Echinococcosis: an emerging or re-emerging zoonosis? Int J Parasitol 2000; 30: 1283-1294
91. Hildreth MB, Sriram S, Gottstein B, Wilson M, Schantz PM. Failure to identify alveolar echinococcosis in trappers from South Dakota in spite of high prevalence of Echinococcus multilocularis in wild canids. J Parasitol 2000; 86: 75-77
92. Doi R, Seo H, Fukuyama Y, Nakao M, Inaoka T, Kutsumi S. Epidemiology of multilocular echinococcosis in Hokkaido. A sero-epidemiological study of hunters. Jap J Pub Health 1987; 34: 357-365
93. Sato N, Aoki S, Matsushita M, Uchino J. Clinical features. In: Uchino J, Sato N, editors. Alveolar echinococcosis of the liver. Sapporo: Hokkaido University School of Medicine, 1993: 63-68
94. Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, Tarr PE, Halkik N, Müllhaupt B. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 2008; 49: 72-77
95. Bartholomot G, Vuitton DA, Harraga S, Shi DZ, Giraudoux P, Barnish G, Wang YH, MacPherson CN, Craig PS. Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China. Am J Trop Med Hyg 2002; 66: 23-29
96. Bresson-Hadni S, Delabrousse E, Blagosklonov O, Bartholomot B, Koch S, Miguet JP, André Mantion G, Angèle Vuitton D. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int 2006; 55 Suppl: S267-S272
97. Reuter S, Nüssle K, Kolokythas O, Haug U, Rieber A, Kern P, Kratzer W. Alveolar liver echinococcosis: a comparative study of three imaging techniques. Infection 2001; 29: 119-125
98. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien PA, Deplazes P, von Schulthess GK, Muellhaupt B, Ammann RW, Renner EL. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 2007; 35: 11-18
99. Kern P, Wen H, Sato N, Vuitton DA, Gruener B, Shao Y, Delabrousse E, Kratzer W, Bresson-Hadni S. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 2006; 55 Suppl: S283-S287
100. Scheuring UJ, Seitz HM, Wellmann A, Hartlapp JH, Tappe D, Brehm K, Spengler U, Sauerbruch T, Rockstroh JK. Longterm benzimidazole treatment of alveolar echinococcosis with hematogenic subcutaneous and bone dissemination. Med Microbiol Immunol 2003; 192: 193-195
101. Ma L, Ito A, Liu YH, Wang XG, Yao YQ, Yu DG, Chen YT. Alveolar echinococcosis: Em2plus-ELISA and Em18-western blots for follow-up after treatment with albendazole. Trans R Soc Trop Med Hyg 1997; 91: 476-478
102. Xiao N, Mamuti W, Yamasaki H, Sako Y, Nakao M, Nakaya K, Gottstein B, Schantz PM, Lightowlers MW, Craig PS, Ito A. Evaluation of use of recombinant Em18 and affinity-purified Em18 for serological differentiation of alveolar echinococcosis from cystic echinococcosis and other parasitic infections. J Clin Microbiol 2003; 41: 3351-3353
103. Ito A, Ma L, Paul M, Stefaniak J, Pawlowski ZS. Evaluation of Em18-, Em16-, antigen B-western blots, Em2plus-ELISA and four other tests for differential serodiagnosis of alveolar and cystic echinococcosis patients in Poland. Parasitol Int 1998; 47: 95-99
104. Gottstein B, Jacquier P, Bresson-Hadni S, Eckert J. Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen. J Clin Microbiol 1993; 31: 373-376
105. Lanier AP, Trujillo DE, Schantz PM, Wilson JF, Gottstein B, McMahon BJ. Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease. Am J Trop Med Hyg 1987; 37: 609-615
106. Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg 1987; 36: 576-585
107. Ito A, Schantz PM, Wilson JF. Em18, a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease. Am J Trop Med Hyg 1995; 52: 41-44
108. Ito A, Xiao N, Liance M, Sato MO, Sako Y, Mamuti W, Ishikawa Y, Nakao M, Yamasaki H, Nakaya K, Bardonnet K, Bresson-Hadni S, Vuitton DA. Evaluation of an enzymelinked immunosorbent assay (ELISA) with affinity-purified Em18 and an ELISA with recombinant Em18 for differential diagnosis of alveolar echinococcosis: results of a blind test. J Clin Microbiol 2002; 40: 4161-4165
109. Vuitton DA, Zhang SL, Yang Y, Godot V, Beurton I, Mantion G, Bresson-Hadni S. Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int 2006; 55 Suppl: S51-S55
110. Wen H, Craig PS, Ito A, Vuitton DA, Bresson-Hadni S, Allan JC, Rogan MT, Paollilo E, Shambesh M. Immunoblot evaluation of IgG and IgG-subclass antibody responses for im-munodiagnosis of human alveolar echinococcosis. Ann Trop Med Parasitol 1995; 89: 485-495
111. Wen H, Craig PS. Immunoglobulin G subclass responses in human cystic and alveolar echinococcosis. Am J Trop Med Hyg 1994; 51: 741-748
112. Dreweck CM, Lüder CG, Soboslay PT, Kern P. Subclassspecific serological reactivity and IgG4-specific antigen recognition in human echinococcosis. Trop Med Int Health 1997; 2: 779-787
113. Wen H, Bresson-Hadni S, Vuitton DA, Lenys D, Yang BM, Ding ZX, Craig PS. Analysis of immunoglobulin G subclass in the serum antibody responses of alveolar echinococcosis patients after surgical treatment and chemotherapy as an aid to assessing the outcome. Trans R Soc Trop Med Hyg 1995; 89: 692-697
114. Yamasaki H, Nakaya K, Nakao M, Sako YAI. Significance of molecular diagnosis using histopathological specimens in cestode zoonoses. Trop Med Health 2007; 35: 307-321
115. Kadry Z, Renner EC, Bachmann LM, Attigah N, Renner EL, Ammann RW, Clavien PA. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg 2005; 92: 1110-1116
116. Buttenschoen K, Carli Buttenschoen D, Gruener B, Kern P, Beger HG, Henne-Bruns D, Reuter S. Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg 2009; 394: 689-698
117. Koch S, Bresson-Hadni S, Miguet JP, Crumbach JP, Gillet M, Mantion GA, Heyd B, Vuitton DA, Minello A, Kurtz S. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report. Transplantation 2003; 75: 856-863
118. Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 2000; 46: 451-456
119. Reuter S, Buck A, Grebe O, Nüssle-Kügele K, Kern P, Manfras BJ. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 2003; 47: 3586-3591
120. Kern P, Abboud P, Kern W, Stich A, Bresson-Hadni S, Guerin B, Buttenschoen K, Gruener B, Reuter S, Hemphill A. Critical appraisal of nitazoxanide for the treatment of alveolar echinococcosis. Am J Trop Med Hyg 2008; 79: 119
121. Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-135